CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Volumetric Incentive Spirometry +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03083379
NCT03083379N/ACompleted

A Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy in Healthy Adult Human Subjects

University of Virginia·interventional·Posted Mar 20, 2017·Updated Jun 14, 2018

In Brief

A clinical study evaluating Volumetric Incentive Spirometry and EzPAP® POSITIVE AIRWAY PRESSURE for Ventilation and 2 related conditions. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The primary purpose of this study is to determine if there is a significant difference in regional distribution of ventilation when comparing eupneic tidal ventilation with Incentive Spirometry (I.S.) and EzPAP® lung expansion therapy in healthy adult human subjects. Electrical impedance tomography (EIT) will be used to measure regional distribution of ventilation during resting tidal ventilation and during lung expansion therapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 20, 2017
Enrollment StartMar 6, 2017
Primary CompletionApr 21, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 9.3 years ago

Interventions

Volumetric Incentive Spirometrydevice

A study investigator will provide instruction on Incentive Spirometry procedure performance before supervised therapy and monitoring begins. * Five minutes of eupneic ventilation EIT monitoring will occur before I.S. therapy commences. * Study participants will be asked to take 10 deep breaths through the incentive spirometer's mouthpiece, followed by a 60 second pause. * The 10-breath cycle will be repeated three times with respiratory therapist coaching. * Five minutes of eupneic ventilation EIT monitoring will occur following the last I.S. lung expansion therapy breath cycle. * Incentive Spirometry therapy and monitoring session will last about 15 minutes

EzPAP® POSITIVE AIRWAY PRESSUREdevice

* A study investigator will provide instruction on EzPAP® procedure performance before supervised therapy and monitoring begins. A second study investigator will perform EIT device set-up and monitoring only. * Five minutes of eupneic ventilation EIT monitoring will occur before EzPAP® therapy commences. * Study participants will be asked to breathe normally through the EzPAP® device's mouthpiece for 10 breaths, followed by a 60 second pause. * The 10-breath cycle will be repeated three times with respiratory therapist coaching. * Five minutes of eupneic ventilation EIT monitoring will occur following the last EzPAP® lung expansion therapy breath cycle. * EzPAP® therapy and monitoring sessions will last about 15 minutes